论文部分内容阅读
目的:通过对妊娠期用药的现状及妊娠期用药风险原因的分析,探讨开展“妊娠期用药风险评估与沟通药师门诊”的必要性。方法:参考美国食品和药品监督管理局(FDA)制定的药物妊娠危险性等级分类,综合研究孕妇服用药物剂量、用药时间、遗传因素、孕期保健和潜在疾病等多方面因素,最终建立“妊娠期用药风险评估与沟通药师门诊”。结果:通过医院信息系统对门诊数据进行回顾,发现孕妇就诊量逐渐增多。临床药师针对产科患者提供的药学服务模式,深受临床医师和患者的肯定。结论:建议医院可设立妊娠期用药风险评估与沟通药师门诊,提高孕妇用药知识水平,促进临床安全用药。
OBJECTIVE: To explore the necessity of carrying out “risk assessment and communication of pharmacist during pregnancy” by analyzing the current situation of medication during pregnancy and the risk factors of medication during pregnancy. Methods: With reference to the classification of drug pregnancy risk grades developed by the U.S. Food and Drug Administration (FDA), we comprehensively studied pregnant women taking different doses of drugs, medication time, genetic factors, prenatal care and potential diseases, finally establishing the “Pregnancy Period medication risk assessment and communication pharmacist outpatient ”. Results: The outpatient data were reviewed through the hospital information system and found that the pregnant women’s attendance increased gradually. Clinical pharmacists for obstetric patients with the pharmacy service model, by clinicians and patients affirmed. Conclusion: It is suggested that the hospital can set up risk assessment and communication pharmacist clinics in pregnancy, improve the knowledge of pregnant women medication, and promote clinical safety medication.